Antares Pharma, Inc.
NASDAQ: ATRS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Robert Apple
- Employees
- 201
- Headquarters
- Ewing, United States
- IPO year
- 1996
- Website
- https://www.antarespharma.com
Loading ATRS…
Loading profile data…Frequently asked questions about ATRS
What does Antares Pharma, Inc. (ATRS) do?
Antares Pharma, Inc. operates as a specialized pharmaceutical enterprise, primarily dedicated to innovating and marketing medicines and advanced technologies. Its core mission is to address critical patient needs across a range of therapeutic areas. The company achieves this by developing, manufacturing, and commercializing groundbreaking therap...
Where does ATRS trade?
Antares Pharma, Inc. (ATRS) trades on the NASDAQ Capital Market.
What sector is ATRS in?
Antares Pharma, Inc. (ATRS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Antares Pharma, Inc.?
Robert Apple is the chief executive officer of Antares Pharma, Inc. (ATRS).
Where is Antares Pharma, Inc. headquartered?
Antares Pharma, Inc. is headquartered in United States.
Does ATRS pay a dividend?
Antares Pharma, Inc. (ATRS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATRS go public?
Antares Pharma, Inc. (ATRS) completed its initial public offering in 1996.